These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Management of the climacteric syndrome exemplified by ambulatory care of menopause at the 1st University Gynecologic Clinic]. Metka M Gynakol Rundsch; 1987; 27(4):252-6. PubMed ID: 2830178 [No Abstract] [Full Text] [Related]
23. [The climacteric and its hormonal treatment]. Gvorgiev DB Akush Ginekol (Sofiia); 1993; 32(1):36-40. PubMed ID: 8172347 [No Abstract] [Full Text] [Related]
25. Does adding estrogen to the hormone-free days of an oral contraceptive (OC) cycle reduce menopausal symptoms in perimenopausal OC users? Bielanski TE J Fam Pract; 2001 Oct; 50(10):838. PubMed ID: 11674879 [No Abstract] [Full Text] [Related]
29. [Substitute estrogen treatment of women after the menopause from the internist's viewpoint]. Chojnowska-Jezierska J Pol Tyg Lek; 1985 Jul; 40(30):852-4. PubMed ID: 3903698 [No Abstract] [Full Text] [Related]
30. Influence of hormone therapy on the cardiovascular responses to stress of postmenopausal women. Matthews KA; Owens JF; Salomon K; Harris KF; Berga SL Biol Psychol; 2005 Apr; 69(1):39-56. PubMed ID: 15740824 [TBL] [Abstract][Full Text] [Related]
32. Comparative cardiovascular effects of different progestins in menopause. Rosano GM; Fini M Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197 [TBL] [Abstract][Full Text] [Related]
33. [Current trends in hormone therapy during menopause and postmenopause]. Suhonen S Duodecim; 1994; 110(10):1011-8. PubMed ID: 7588094 [No Abstract] [Full Text] [Related]
34. [Social medicine aspects of pre- and postmenopause]. Schmeiser-Rieder A; Concin H; Schwarz B; Kunze M Wien Med Wochenschr; 1995; 145(14):331-3. PubMed ID: 7483647 [TBL] [Abstract][Full Text] [Related]
35. Impact of postmenopausal hormone therapy on cardiovascular events and cancer. Inclusion of one particular study was inappropriate. al-Azzawi F; Thompson J; Halligan A BMJ; 1997 Sep; 315(7109):677-8. PubMed ID: 9310579 [No Abstract] [Full Text] [Related]
36. [Climacteric disorders and the principles of hormone replacement therapy]. Smetnik VP Ter Arkh; 1995; 67(10):70-4. PubMed ID: 8779115 [No Abstract] [Full Text] [Related]
38. [Postmenopausal hormone replacement and cardiovascular disease]. Oian P; Aune B Tidsskr Nor Laegeforen; 1993 Jan; 113(2):193-6. PubMed ID: 8430399 [TBL] [Abstract][Full Text] [Related]
39. [Estrogen treatment of women in their climacteric]. Fock D Katilolehti; 1978 Apr; 83(4):144-6. PubMed ID: 247035 [No Abstract] [Full Text] [Related]
40. [Hormone replacement therapy with 17 beta-estradiol dydrogesterone: results of a 3-month open-label study]. Grisar J; Travica S; Metka M; Pietschmann P Wien Klin Wochenschr; 1999 Dec; 111(24):1035-43. PubMed ID: 10677891 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]